Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohnʼs disease-Reference-Cited by-同舟云学术

Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohnʼs disease

Published:2009-10 Issue:10 Volume:15 Page:1599-1604
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:Inflammatory Bowel Diseases

Author:

DʼHaens Geert R.,Fedorak Richard,Lémann Marc,Feagan Brian G.,Kamm Michael A.,Cosnes Jacques,Rutgeerts Paul J.,Marteau Philippe,Travis Simon,Schölmerich Jürgen,Hanauer Steven,Sandborn William J.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Reference47 articles.

1. Inflammatory bowel disease: cause and immunobiology

2. Inflammatory bowel disease: clinical aspects and established and evolving therapies

3. Disease Activity Courses in a Regional Cohort of Crohn's Disease Patients

4. Intestinal cancer risk and mortality in patients with Crohn's disease

5. Predictability of the postoperative course of Crohn's disease

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Endoscopic Scoring Systems in Inflammatory Bowel Disease;Gastrointestinal Endoscopy Clinics of North America;2024-06

2. Usefulness of Serum Leucine-rich Alpha 2 Glycoprotein in Crohn’s Disease: Is There Any Difference between Small Intestine and Colonic Lesions?;Crohn's & Colitis 360;2023-05-23

3. Ileocecal valve that cannot be intubated in Crohn’s disease: is this a sign of poor prognosis?;International Journal of Colorectal Disease;2023-04-19

4. Ileocecal valve that cannot be intubated in Crohn’s disease: Is this a sign of poor prognosis?;2023-02-09

5. Accuracy of Serum Leucine-Rich Alpha-2 Glycoprotein in Evaluating Endoscopic Disease Activity in Crohn’s Disease;Inflammatory Bowel Diseases;2022-04-18